Ying Chu

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 3

Top Topics

Rheumatoid Arthritis

Molecular Docking

Interstitial Lung Disease

Signaling Pathway

Top Venues

Drug design, development and therapy

Cancer management and research

This page only lists publications with an associated author ORCID identifier.

Publications

Qingyang Liu, Jian Wang, Chunhui Ding, Ying Chu, Fengying Jiang, Yunxia Hu, Haifeng Li, Qiubo Wang
Sinomenine Alleviates Rheumatoid Arthritis by Suppressing the PI3K-Akt Signaling Pathway, as Demonstrated Through Network Pharmacology, Molecular Docking, and Experimental Validation. Drug design, development and therapy 18 (2024)
Qingyang Liu, Jian Wang, Chunhui Ding, Ying Chu, Fengying Jiang, Yunxia Hu, Haifeng Li, Qiubo Wang
Sinomenine Alleviates Rheumatoid Arthritis by Suppressing the PI3K-Akt Signaling Pathway, as Demonstrated Through Network Pharmacology, Molecular Docking, and Experimental Validation. Drug design, development and therapy 18 (2024)
Ying Chu, Yi Chang, Wei Lu, Xiumei Sheng, Shengjun Wang, Huaxi Xu, Jie Ma
Regulation of Autophagy by Glycolysis in Cancer. Cancer management and research 12 (2020)